Characterisation of a novel oncogene in breast cancer

Mitchell, Christina (Primary Chief Investigator (PCI))
Ellisdon, Andrew (Chief Investigator (CI))
McLean, Catriona (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/16 → 31/12/21

Funding

NHMRC - National Health and Medical Research Council (Australia): A$1,118,325.00

The FDA-Approved Drug Pyrvinium Selectively Targets ER⁺ Breast Cancer Cells with High INPP4B Expression
Rodgers, S. J., Ooms, L. M. & Mitchell, C. A., Jan 2023, In: Cancers. 15, 1, 13 p., 135.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

6 Link opens in a new tab Citations (Scopus)
A late endosome signaling hub that couples PI3Kα and WNT/β-catenin signaling in breast cancer
Rodgers, S. J., Hamila, S. A., Mitchell, C. A. & Ooms, L. M., 2021, In: Molecular and Cellular Oncology. 8, 4, 3 p., 1954470.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

4 Link opens in a new tab Citations (Scopus)
INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer
Rodgers, S. J., Ooms, L. M., Oorschot, V. M. J., Schittenhelm, R. B., Nguyen, E. V., Hamila, S. A., Rynkiewicz, N., Gurung, R., Eramo, M. J., Sriratana, A., Fedele, C. G., Caramia, F., Loi, S., Kerr, G., Abud, H. E., Ramm, G., Papa, A., Ellisdon, A. M., Daly, R. J. & McLean, C. A. & 1 others, Mitchell, C. A., 2021, In: Nature Communications. 12, 1, 19 p., 3140.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

54 Link opens in a new tab Citations (Scopus)

Australian Synchrotron
Office of the Vice-Provost (Research and Research Infrastructure)
Facility/equipment: Facility